|
2024
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and scien... |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide access ... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and gene ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immuno... |
|
|
G/S
|
Capital investment; investment management; equity capital
investment; providing venture capital,... |
|
|
G/S
|
Medical apparatuses |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic disease... |
|
|
G/S
|
Medical assistance services in the field of treatment of cardiovascular diseases; Providing medic... |
|
|
Invention
|
Rodent anmals expressing human cr1.
Disclosed herein are genetically modified rodent animals com... |
|
|
Invention
|
Anti-trkb monoclonal antibodies and methods of use.
The present invention provides antibodies th... |
|
|
Invention
|
High concentration protein formulation.
The present invention pertains to compositions and metho... |
|
|
Invention
|
Anti-vegf protein compositions and methods for producing the same.
The present disclosure pertai... |
|
|
Invention
|
Anti-npr1 antibodies and uses thereof.
The present invention provides monoclonal antibodies that... |
|
|
Invention
|
Taurine supplemented cell culture medium and methods of use.
The specification describes a compo... |
|
|
Invention
|
Methods and compositions for insertion of antibody coding sequences into a safe harbor locus.
Me... |
|
|
Invention
|
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion prot... |
|
|
Invention
|
Chimeric antigen receptors with bcma specificity and uses thereof.
B-cell maturation antigen (BC... |
|
|
Invention
|
Anti-staphylococcus antibodies and uses thereof.
Speciated antibodies or antigen-binding fragmen... |
|
|
G/S
|
Medical and pharmaceutical consultation; Medical assistance services; Medical information |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, ... |
|
|
G/S
|
Anti-inflammatory preparations; anti-viral agents; pharmaceutical anti-allergic preparations and ... |
|
|
Invention
|
Human antibodies to pd-1.
The present invention provides antibodies that bind to the T-cell co-i... |
|
|
Invention
|
Novel antigen binding molecule formats.
Antigen binding molecules (ABMs) comprising Fab domains ... |
|
|
Invention
|
Methods for treating eosinophilic gastroenteritis by administering an il-4r antagonist. Methods f... |
|
|
Invention
|
Bracketing device for manufacturing parts cleaner and methods therefor. A bracketing device confi... |
|
|
Invention
|
Bracketing device for manufacturing parts cleaner and methods therefor.
A bracketing device conf... |
|
|
Invention
|
Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antag... |
|
|
Invention
|
Methods and compositions for sensitization of tumor cells to immune therapy.
Provided herein are... |
|
|
Invention
|
Proteomic risk score for osteoarthritis (oa). Methods of determining the risk of developing osteo... |
|
|
Invention
|
Proteomic risk score for osteoarthritis (oa).
Methods of determining the risk of developing oste... |
|
|
Invention
|
Methods for obtaining antibody molecules with high affinity. Disclosed herein are methods for obt... |
|
|
Invention
|
Systems and methods for identifying events in supply chain processes. A method for identifying an... |
|
|
Invention
|
Systems and methods for identifying events in supply chain processes.
A method for identifying a... |
|
|
Invention
|
Methods of treating cancer with bispecific anti-cd22 x anti-cd28 molecules. The present disclosur... |
|
|
Invention
|
Combination of pd-1 inhibitors and lag-3 inhibitors for enhanced efficacy in treating melanoma. e... |
|
|
Invention
|
Adam6 mice.
Mice are provided that comprise a reduction or deletion of ADAM6 activity from an en... |
|
|
Invention
|
Anti-fel d1 antibody formulations. The present disclosure provides pharmaceutical formulations co... |
|
|
Invention
|
T cell activators and methods of use thereof. e.g.e.g., dimeric) molecules comprising a peptide-M... |
|
|
Invention
|
Ace2-igm-fc fusion proteins and uses thereof.
The present disclosure provides ACE2 fusion protei... |
|
|
Invention
|
Multivalent anti-spike protein binding molecules and uses thereof.
The present disclosure provid... |
|
|
Invention
|
Ace2-igm-fc fusion proteins and uses thereof. The present disclosure provides ACE2 fusion protein... |
|
|
Invention
|
Multivalent anti-spike protein binding molecules and uses thereof. e.g.e.g., to treat conditions ... |
|
|
Invention
|
Multivalent anti-spike protein binding molecules and uses thereof. The present disclosure provide... |
|
|
Invention
|
Liquid phase peptide support synthesis of peptides and peptidomimetics. The present invention pro... |
|
|
Invention
|
Pd-1 homing endonuclease variants, compositions, and methods of use.
The present disclosure prov... |
|
|
G/S
|
Capital investment; Investment management; Equity capital investment; Providing venture capital, ... |
|
|
Invention
|
Radiolabeled anti-lag3 antibodies for immuno-pet imaging.
The use of anti-LAG3 antibodies or ant... |
|
|
Invention
|
Non-human animals expressing humanized cd3 complex.
Non-human animals, expressing humanized CD3 ... |
|
|
Invention
|
Modulators of hsd17b13 and methods of use thereof.
The disclosure relates to compounds and pharm... |
|
2023
|
Invention
|
Radiolabeled met binding proteins for immuno-pet imaging.
Radiolabeled anti-MET antibodies and M... |
|
|
Invention
|
Human lambda light chain mice.
Genetically modified mice are provided that express human λ varia... |
|
|
Invention
|
Non-human animals having a humanized programmed cell death 1 gene.
Non-human animals, and method... |
|
2022
|
Invention
|
Human antibodies to ebola virus glycoprotein.
The present invention provides monoclonal antibodi... |
|
|
Invention
|
Methods of effecting a hemodynamic change by administering an anti-npr1 antibody.
The present di... |
|
|
Invention
|
Packaging |
|
|
Invention
|
Butyrophilin-like 2 agents for treating inflammatory disorders.
This disclosure provides methods... |
|
|
Invention
|
Utilization of antibodies to shape antibody responses to an antigen.
Described herein are method... |
|
|
Invention
|
Anti-egfrviii antibody drug conjugates and uses thereof.
The present disclosure provides antibod... |
|
2021
|
Invention
|
Nucleic acids encoding anchor modified antibodies and uses thereof.
Described herein are anchor-... |
